keyword
MENU ▼
Read by QxMD icon Read
search

cystectomy

keyword
https://www.readbyqxmd.com/read/27901350/blood-transfusion-requirement-and-not-preoperative-anaemia-is-associated-with-perioperative-complications-following-intracorporeal-robotic-assisted-radical-cystectomy
#1
Wei Shen Tan, Benjamin Wilfrid Lamb, Pramit Khetrapal, Mae-Yen Tan, Melanie El Tan, Ashwin Sridhar, Elizabeth Cervi, Simon Rodney, Gerald Busuttil, Senthil Nathan, John Hines, Greg Shaw, Anna Mohammed, Hilary Baker, Timothy P Briggs, Andrew Klein, Toby Richards, John D Kelly
OBJECTIVES: To assess the prevalence of preoperative anaemia and the impact of preoperative anaemia and blood transfusion requirement on 30- and 90-day complications in a cohort of patients undergoing robotic assisted radical cystectomy with intracorporeal urinary diversion (iRARC). PATIENTS & METHODS: IRARC was performed on 166 patients between June 2011-March 2016. Prospective data was collected for patient demographics, clinical and pathological characteristics, perioperative variables, transfusion requirements and hospital length of stay...
November 30, 2016: Journal of Endourology
https://www.readbyqxmd.com/read/27900539/seom-clinical-guideline-for-treatment-of-muscle-invasive-and-metastatic-urothelial-bladder-cancer-2016
#2
M Lázaro, E Gallardo, M Doménech, Á Pinto, A González Del Alba, J Puente, O Fernández, A Font, N Lainez, S Vázquez
The goal of this article is to provide recommendations for the diagnosis and treatment of muscle-invasive and metastatic bladder cancer. The diagnosis of muscle-invasive bladder cancer is made by pathologic evaluation after transurethral resection. Recently, a molecular classification has been proposed. Staging of muscle-invasive bladder cancer must be done by computed tomography scans of the chest, abdomen and pelvis and classified on the basis of UICC system. Radical cystectomy and lymph node dissection are the treatment of choice...
November 29, 2016: Clinical & Translational Oncology
https://www.readbyqxmd.com/read/27896578/is-there-evidence-for-a-close-connection-between-side-of-intravesical-tumor-location-and-ipsilateral-lymphatic-spread-in-lymph-node-positive-bladder-cancer-patients-at-radical-cystectomy-results-of-the-prometrics-2011-database
#3
M May, C Protzel, M W Vetterlein, M Gierth, J Noldus, A Karl, T Grimm, B Wullich, M O Grimm, P Nuhn, P J Bastian, J Roigas, B Hadaschik, C Gilfrich, M Burger, M Fisch, S Brookman-May, A Aziz, O W Hakenberg
PURPOSE: To evaluate the possible association between bladder tumor location and the laterality of positive lymph nodes (LN) in a prospectively collected multi-institutional radical cystectomy (RC) series. METHODS: The study population included 148 node-positive bladder cancer (BC) patients undergoing RC and pelvic lymph node dissection in 2011 without neoadjuvant chemotherapy and without distant metastasis. Tumor location was classified as right, left or bilateral and compared to the laterality of positive pelvic LN...
November 28, 2016: International Urology and Nephrology
https://www.readbyqxmd.com/read/27895860/hydatid-liver-cyst-causing-portal-vein-thrombosis-and-cavernous-transformation-a-case-report-and-literature-review
#4
Serdar Kirmizi, Cuneyt Kayaalp, Sezai Yilmaz
A 33-year-old male with abdominal distention after meals was admitted to the hospital. He had a history of surgery for hydatid liver cyst. The cyst was located at the liver hilum and there were portal venous thrombosis and cavernous transformation. It had been treated with partial cystectomy, omentoplasty and albendazole. Two years later at the admission to our center, his laboratory tests were in normal ranges. Abdominal imaging methods revealed splenomegaly, portal vein thrombosis, cavernous transformation and the previously operated hydatid liver cyst...
2016: Gastroenterology and Hepatology From Bed to Bench
https://www.readbyqxmd.com/read/27895761/c5a-receptor-expression-is-associated-with-poor-prognosis-in-urothelial-cell-carcinoma-patients-treated-with-radical-cystectomy-or-nephroureterectomy
#5
Yoshihiro Wada, Yoshihiro Maeda, Tatsuko Kubo, Ken Kikuchi, Masatoshi Eto, Takahisa Imamura
Patients with aggressive urothelial cell carcinoma (UCC) that undergo radical cystectomy or nephroureterectomy exhibit markedly high rates of disease recurrence and mortality. To select appropriate adjuvant thxerapies in addition to radical surgery, the identification of predictive prognostic markers for UCC patients is required. The aim of the present study was to identify such markers, by evaluating the association of UCC complement component 5 (C5) fragment a (C5a)receptor (C5aR) expression, detected using immunohistochemistry, with clinicopathological parameters and survival outcomes of UCC patients...
November 2016: Oncology Letters
https://www.readbyqxmd.com/read/27894977/granular-cell-tumor-of-the-bladder-a-rare-neoplasm-managed-with-robotic-partial-cystectomy-using-near-infrared-filter-guidance
#6
Vidhush K Yarlagadda, Daniel G Benson, Jennifer B Gordetsky, Soroush Rais-Bahrami
No abstract text is available yet for this article.
November 25, 2016: Urology
https://www.readbyqxmd.com/read/27894777/efficacy-of-long-acting-octreotide-on-reducing-mucus-production-in-patients-with-ileal-neobladder
#7
Mohammad Hatef Khorrami, Amir Javid, Mohammad Hossein Izadpanahi, Farshid Alizadeh, Mahtab Zargham, Farbod Khorrami
PURPOSE: To evaluate the efficacy of long-acting-release octreotide (trade name Sandostatin) on decreasing mucus secretion, thus reducing catheter obstruction after radical cystectomy and orthotopic reconstruction. PATIENTS AND METHODS: In this double-blind, placebo-controlled study, we treated 73 cases of radical cystectomy between the years 2008 and 2014; 65 were deemed eligible for the study. Cases were randomly divided into 2 groups. Group A (n = 32) received 2 doses of 20 mg intramuscular long-acting-release octreotide 4 weeks before and on the day of surgery, while group B (n = 33) received placebo...
November 4, 2016: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/27894318/surgical-treatment-of-recurrent-urachal-carcinoma-with-liver-metastasis-a-case-report-and-literature-review
#8
Lukasz Paschke, Miroslaw Juszczak, Maciej Slupski
BACKGROUND: Urachal carcinoma is a rare malignancy with poor prognosis due to late presentation of the disease and its aggressiveness. Surgery remains the mainstay of therapy even in cases of disease recurrence. To the best of our knowledge, this is the first report of salvage surgery in the case of urachal carcinoma with liver metastasis. CASE PRESENTATION: The patient was a young woman who suffered from locally advanced urachal carcinoma treated with en-bloc cystectomy, hysterectomy with bilateral adnexectomy, partial resection of the sigmoid colon, and partial resection of the rectus abdominis muscle with the fascia, skin, and umbilicus...
November 28, 2016: World Journal of Surgical Oncology
https://www.readbyqxmd.com/read/27894096/shed-urinary-alcam-is-an-independent-prognostic-biomarker-of-three-year-overall-survival-after-cystectomy-in-patients-with-bladder-cancer
#9
Shanna A Arnold Egloff, Liping Du, Holli A Loomans, Alina Starchenko, Pei-Fang Su, Tatiana Ketova, Paul B Knoll, Jifeng Wang, Ahmed Q Haddad, Oluwole Fadare, Justin M Cates, Yair Lotan, Yu Shyr, Peter E Clark, Andries Zijlstra
Proteins involved in tumor cell migration can potentially serve as markers of invasive disease. Activated Leukocyte Cell Adhesion Molecule (ALCAM) promotes adhesion, while shedding of its extracellular domain is associated with migration. We hypothesized that shed ALCAM in biofluids could be predictive of progressive disease. ALCAM expression in tumor (n = 198) and shedding in biofluids (n = 120) were measured in two separate VUMC bladder cancer cystectomy cohorts by immunofluorescence and enzyme-linked immunosorbent assay, respectively...
November 24, 2016: Oncotarget
https://www.readbyqxmd.com/read/27890686/cardiac-and-skeletal-muscles-metastases-from-squamous-cell-carcinoma-of-the-bladder-pet-ct-findings
#10
Luis Gorospe, Ernesto García-Santana, Pablo Jane-Soler, María Del Val Gómez-Martínez, Victoria Gómez-Dos-Santos, Isabel García-Gómez-Muriel, Raquel García-Latorre
We describe the PET/CT findings of a patient who underwent a radical cystectomy six months earlier because of a squamous cell carcinoma of the bladder (SCCB) that presented to the ER with chest pain and palpitations. Cardiac catheterization ruled out coronary artery occlusion, but PET/CT showed multiple FDG-avid lesions involving multiple skeletal muscles and the heart, consistent with metastases. A CT-guided biopsy of one skeletal muscle lesion confirmed a metastasis with the same pathologic features as the SCCB...
November 24, 2016: Urology
https://www.readbyqxmd.com/read/27887944/facing-the-fate-of-the-remnant-urothelium-after-radical-cystectomy-there-is-room-for-improvement
#11
EDITORIAL
Malte W Vetterlein, Felix K-H Chun, Luis A Kluth
No abstract text is available yet for this article.
November 22, 2016: European Urology
https://www.readbyqxmd.com/read/27885456/-intravesical-radioimmunotherapy-of-carcinoma-in-situ-of-the-urinary-bladder-after-bcg-failure
#12
M E Autenrieth, T Horn, F Kurtz, K Nguyen, A Morgenstern, F Bruchertseifer, M Schwaiger, M Blechert, C Seidl, R Senekowitsch-Schmidtke, J E Gschwend, K Scheidhauer
BACKGROUND: In failure to respond to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ (CIS) of the urinary bladder, radical cystectomy remains the mainstay after BCG failure. OBJECTIVES: The aim of this pilot study was to evaluate tolerability and safety of the α‑emitter radioimmunoconjugate instillation in patients after BCG failure. MATERIALS AND METHODS: Nine patients were included. After emptying the bladder via a transurethral catheter, Bi-213-anti-EGFR-mAb was instilled...
November 24, 2016: Der Urologe. Ausg. A
https://www.readbyqxmd.com/read/27874062/systemic-perioperative-management-of-muscle-invasive-bladder-cancer-and-future-horizons
#13
REVIEW
Samuel A Funt, Jonathan E Rosenberg
Many patients diagnosed with muscle-invasive bladder cancer (MIBC) will develop distant metastatic disease. Over the past three decades, perioperative cisplatin-based chemotherapy has been investigated for its ability to reduce the number of deaths from bladder cancer. Insufficient evidence is available to fully support the use of such chemotherapy in the adjuvant setting; however, neoadjuvant cisplatin-based combination chemotherapy has become a standard of care for eligible patients based on the improved disease-specific and overall survival demonstrated in two randomized phase III trials, compared with surgery alone...
November 22, 2016: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/27873153/preoperative-determinant-of-early-postoperative-renal-function-following-radical-cystectomy-and-intestinal-urinary-diversion
#14
Tatsuo Gondo, Yoshio Ohno, Jun Nakashima, Takeshi Hashimoto, Yoshihiro Nakagami, Masaaki Tachibana
PURPOSE: To identify preoperative factors correlated with postoperative early renal function in patients who had undergone radical cystectomy (RC) and intestinal urinary diversion. METHODS: We retrospectively identified 201 consecutive bladder cancer patients without distant metastasis who had undergone RC at our institution between 2003 and 2012. The estimated glomerular filtration rate (eGFR) was calculated using the modified Chronic Kidney Disease Epidemiology equation before RC and 3 months following RC...
November 21, 2016: International Urology and Nephrology
https://www.readbyqxmd.com/read/27869092/erratum-to-baumann-bc-bosch-wr-bahl-a-et-al-development-and-validation-of%C3%A2-consensus-contouring-guidelines-for-adjuvant-radiation-therapy-for-bladder-cancer-after-radical-cystectomy-int-j-radiat-oncol-biol-phys-2016-96-78-86
#15
(no author information available yet)
No abstract text is available yet for this article.
December 1, 2016: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/27867338/bladder-leiomyosarcoma-a-rare-but-aggressive-diagnosis
#16
Mathew Fakhoury, Richard R Hwang, Joseph Silletti, Marc A Bjurlin
It remains evident in the literature that leiomyosarcomas of the bladder have continuously been regarded as highly aggressive tumors associated with a poor prognosis. Immediate surgical therapy by radical cystectomy with wide margins is warranted as an effective treatment modality and has been associated with longer survival rates. Herein, we present the case of a high-grade leiomyosarcoma primarily treated with anterior pelvic exenteration and urinary diversion.
October 2016: Current Urology
https://www.readbyqxmd.com/read/27866842/upholding-rigorous-standards-comparable-patterns-and-rates-of-recurrence-between-open-and-robot-assisted-radical-cystectomy
#17
EDITORIAL
Nieroshan Rajarubendra, Monish Aron
No abstract text is available yet for this article.
November 17, 2016: European Urology
https://www.readbyqxmd.com/read/27866245/the-impact-of-socioeconomic-status-on-perioperative-complications-and-oncologic-outcomes-in-patients-undergoing-radical-cystectomy
#18
David M Golombos, Padraic O'Malley, Patrick Lewicki, Daniel P Nguyen, Benjamin V Stone, Bashir Al Hussein Al Awamlh, Douglas S Scherr
PURPOSE: To examine if patients of lower socioeconomic status (SES) are at higher risk of perioperative complications and experience different oncologic outcomes after radical cystectomy (RC). METHODS: Retrospective review was performed on 383 consecutive non-metastatic patients who underwent definitive RC at a tertiary referral center. Along with clinical and pathologic parameters traditionally utilized for risk stratification, potential social determinants of health were estimated using US Census data...
November 19, 2016: World Journal of Urology
https://www.readbyqxmd.com/read/27865750/outcomes-following-radical-cystectomy-for-plasmacytoid-urothelial-carcinoma-defining-the-need-for-improved-local-cancer-control
#19
Patrick A Cockerill, John C Cheville, Stephen A Boorjian, Andrew Blackburne, Prabin Thapa, Robert F Tarrell, Igor Frank
OBJECTIVE: To evaluate oncologic outcomes after radical cystectomy (RC) in patients with plasmacytoid urothelial carcinoma (UC), and compared survival to that in patients with pure UC of the bladder. METHODS: We identified 46 patients with plasmacytoid UC and 972 with pure UC who were treated with RC between 1980 and 2009. All pathologic specimens were re-reviewed by a single GU pathologist. Patients were matched 1:2 by age, gender, ECOG performance status, pathological tumor stage and nodal status to patients with pure UC...
November 16, 2016: Urology
https://www.readbyqxmd.com/read/27862828/introduction-of-robotically-assisted-radical-cystectomy-within-an-established-enhanced-recovery-programme
#20
Catherine Miller, Nicholas J Campain, Rachel Dbeis, Mark Daugherty, Nicholas Batchelor, Elizabeth Waine, John S McGrath
OBJECTIVES: In recent years, there has been rapid adoption of robotically-assisted surgery (RAS) for the treatment of pelvic urological cancers. This is particularly true for radical prostatectomy (RP) where robotically-assisted laparoscopic prostatectomy (RALP) has become the predominant surgical approach across England. Despite this, less than 15% of patients undergoing radical cystectomy (RC) in England in 2014 underwent a robotically-assisted radical cystectomy (RARC). However, as expertise in RAS spreads, an increasing number of cancer centres are now adopting this approach for patients undergoing RC...
November 15, 2016: BJU International
keyword
keyword
64184
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"